Literature DB >> 26594552

Crystal structure of 3-chloro-1-methyl-5-nitro-1H-indazole.

Assoman Kouakou1, El Mostapha Rakib1, Mohamed Chigr1, Mohamed Saadi2, Lahcen El Ammari2.   

Abstract

The mol-ecule of the title compound, C8H6ClN3O2, is built up from fused five- and six-membered rings connected to a chlorine atom and to nitro and methyl groups. The indazole system is essentially planar with the largest deviation from the mean plane being 0.007 (2) Å. No classical hydrogen bonds are observed in the structure. Two mol-ecules form a dimer organised by a symmetry centre via a close contact between a nitro-O atom and the chlorine atom [at 3.066 (2) Å this is shorter than the sum of their van der Waals radii].

Entities:  

Keywords:  Cl⋯O short contact; crystal structure; indazole derivative

Year:  2015        PMID: 26594552      PMCID: PMC4645045          DOI: 10.1107/S2056989015018411

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Related literature

For biological activities such as as anti­microbial, anti­cancer, anti­inflammatory, anti­platelet and selective 5-HT6 antagonists of the title compound and derivatives, see: Schmidt et al. (2008 ▸); Shafakat Ali et al. (2012 ▸); Abbassi et al. (2014 ▸); Plescia et al. (2010 ▸); Lee et al. (2001 ▸); Liu et al. (2011 ▸).

Experimental

Crystal data

C8H6ClN3O2 M = 211.61 Monoclinic, a = 3.8273 (2) Å b = 14.678 (6) Å c = 15.549 (6) Å β = 96.130 (9)° V = 868.5 (6) Å3 Z = 4 Mo Kα radiation μ = 0.41 mm−1 T = 296 K 0.31 × 0.27 × 0.21 mm

Data collection

Bruker X8 APEX Diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▸) T min = 0.654, T max = 0.747 19793 measured reflections 2243 independent reflections 1963 reflections with I > 2σ(I) R int = 0.028

Refinement

R[F 2 > 2σ(F 2)] = 0.043 wR(F 2) = 0.115 S = 1.10 2243 reflections 127 parameters H-atom parameters constrained Δρmax = 0.36 e Å−3 Δρmin = −0.27 e Å−3

Data collection: APEX2 (Bruker, 2009 ▸); cell refinement: SAINT (Bruker, 2009 ▸); data reduction: SAINT; program(s) used to solve structure: SHELXS2013 (Sheldrick, 2008 ▸); program(s) used to refine structure: SHELXL2013 (Sheldrick, 2015 ▸); molecular graphics: ORTEP-3 (Burnett & Johnson, 1996 ▸; Farrugia, 2012 ▸); software used to prepare material for publication: publCIF (Westrip, 2010 ▸). Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015018411/zp2019sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015018411/zp2019Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989015018411/zp2019Isup3.cml Click here for additional data file. . DOI: 10.1107/S2056989015018411/zp2019fig1.tif Plot of the mol­ecule of the title compound with the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms are represented as small circles. CCDC reference: 1429148 Additional supporting information: crystallographic information; 3D view; checkCIF report
C8H6ClN3O2Dx = 1.618 Mg m3
Mr = 211.61Melting point: 471 K
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
a = 3.8273 (2) ÅCell parameters from 2243 reflections
b = 14.678 (6) Åθ = 2.6–28.7°
c = 15.549 (6) ŵ = 0.41 mm1
β = 96.130 (9)°T = 296 K
V = 868.5 (6) Å3Block, colourless
Z = 40.31 × 0.27 × 0.21 mm
F(000) = 432
Bruker X8 APEX Diffractometer2243 independent reflections
Radiation source: fine-focus sealed tube1963 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.028
φ and ω scansθmax = 28.7°, θmin = 2.6°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −5→5
Tmin = 0.654, Tmax = 0.747k = −19→19
19793 measured reflectionsl = −20→20
Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.043H-atom parameters constrained
wR(F2) = 0.115w = 1/[σ2(Fo2) + (0.0484P)2 + 0.5276P] where P = (Fo2 + 2Fc2)/3
S = 1.10(Δ/σ)max < 0.001
2243 reflectionsΔρmax = 0.36 e Å3
127 parametersΔρmin = −0.27 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
Cl10.39641 (14)0.41233 (3)0.10469 (3)0.04683 (17)
N30.7340 (4)0.56202 (10)0.29223 (9)0.0345 (3)
N20.6938 (4)0.48003 (10)0.25083 (10)0.0358 (3)
N10.0460 (5)0.79442 (11)0.05310 (10)0.0416 (4)
O2−0.0907 (5)0.75957 (11)−0.01323 (11)0.0671 (5)
O10.0360 (6)0.87596 (11)0.06625 (11)0.0669 (5)
C30.4260 (4)0.59119 (11)0.16618 (10)0.0283 (3)
C40.5778 (4)0.63052 (11)0.24420 (10)0.0299 (3)
C20.2473 (4)0.64453 (11)0.10193 (10)0.0301 (3)
H20.14590.61960.05020.036*
C10.2289 (5)0.73599 (12)0.11912 (11)0.0325 (3)
C70.5114 (4)0.49799 (12)0.17658 (11)0.0320 (3)
C50.5521 (5)0.72408 (12)0.26022 (11)0.0373 (4)
H50.64980.74970.31200.045*
C60.3773 (5)0.77622 (12)0.19662 (12)0.0381 (4)
H60.35640.83870.20470.046*
C90.9194 (5)0.56629 (15)0.37845 (12)0.0442 (5)
H9A1.00180.50660.39570.066*
H9B1.11600.60690.37850.066*
H9C0.76340.58820.41820.066*
U11U22U33U12U13U23
Cl10.0591 (3)0.0334 (2)0.0457 (3)0.00152 (19)−0.0049 (2)−0.01074 (18)
N30.0347 (8)0.0374 (8)0.0308 (7)−0.0012 (6)0.0006 (6)−0.0012 (6)
N20.0367 (8)0.0345 (7)0.0360 (7)0.0011 (6)0.0033 (6)−0.0012 (6)
N10.0497 (9)0.0357 (8)0.0405 (8)0.0048 (7)0.0095 (7)0.0062 (6)
O20.0955 (14)0.0476 (9)0.0513 (9)0.0052 (9)−0.0246 (9)0.0045 (7)
O10.1054 (15)0.0352 (8)0.0589 (10)0.0147 (9)0.0037 (9)0.0054 (7)
C30.0266 (8)0.0304 (8)0.0285 (7)−0.0028 (6)0.0056 (6)−0.0032 (6)
C40.0270 (8)0.0348 (8)0.0284 (7)−0.0043 (6)0.0051 (6)−0.0020 (6)
C20.0310 (8)0.0321 (8)0.0276 (7)−0.0024 (6)0.0048 (6)−0.0014 (6)
C10.0342 (9)0.0315 (8)0.0328 (8)−0.0001 (7)0.0084 (7)0.0029 (6)
C70.0317 (8)0.0314 (8)0.0331 (8)−0.0018 (6)0.0047 (6)−0.0039 (6)
C50.0430 (10)0.0359 (9)0.0330 (8)−0.0069 (7)0.0044 (7)−0.0093 (7)
C60.0463 (10)0.0283 (8)0.0407 (9)−0.0028 (7)0.0100 (8)−0.0058 (7)
C90.0422 (10)0.0559 (12)0.0326 (9)−0.0021 (9)−0.0055 (8)−0.0008 (8)
Cl1—C71.7086 (18)C4—C51.401 (2)
N3—C41.353 (2)C2—C11.372 (2)
N3—N21.366 (2)C2—H20.9300
N3—C91.450 (2)C1—C61.406 (3)
N2—C71.311 (2)C5—C61.367 (3)
N1—O11.215 (2)C5—H50.9300
N1—O21.218 (2)C6—H60.9300
N1—C11.458 (2)C9—H9A0.9600
C3—C21.390 (2)C9—H9B0.9600
C3—C41.411 (2)C9—H9C0.9600
C3—C71.412 (2)
C4—N3—N2111.95 (14)C2—C1—N1117.97 (16)
C4—N3—C9128.47 (16)C6—C1—N1118.43 (16)
N2—N3—C9119.56 (16)N2—C7—C3113.01 (15)
C7—N2—N3105.10 (14)N2—C7—Cl1120.27 (14)
O1—N1—O2122.53 (18)C3—C7—Cl1126.72 (13)
O1—N1—C1118.81 (17)C6—C5—C4117.27 (16)
O2—N1—C1118.66 (16)C6—C5—H5121.4
C2—C3—C4120.87 (15)C4—C5—H5121.4
C2—C3—C7135.89 (15)C5—C6—C1120.43 (16)
C4—C3—C7103.23 (14)C5—C6—H6119.8
N3—C4—C5131.73 (16)C1—C6—H6119.8
N3—C4—C3106.71 (15)N3—C9—H9A109.5
C5—C4—C3121.56 (16)N3—C9—H9B109.5
C1—C2—C3116.26 (15)H9A—C9—H9B109.5
C1—C2—H2121.9N3—C9—H9C109.5
C3—C2—H2121.9H9A—C9—H9C109.5
C2—C1—C6123.60 (16)H9B—C9—H9C109.5
  6 in total

1.  Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists.

Authors:  Kevin G Liu; Albert J Robichaud; Alexander A Greenfield; Jennifer R Lo; Cristina Grosanu; James F Mattes; Yanxuan Cai; Guo Ming Zhang; Jean Y Zhang; Dianne M Kowal; Deborah L Smith; Li Di; Edward H Kerns; Lee E Schechter; Thomas A Comery
Journal:  Bioorg Med Chem       Date:  2010-10-20       Impact factor: 3.641

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.

Authors:  Nasir ali Shafakat Ali; Shaikh Zakir; Muqtadir Patel; Mazahar Farooqui
Journal:  Eur J Med Chem       Date:  2012-01-30       Impact factor: 6.514

4.  Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents.

Authors:  F Y Lee; J C Lien; L J Huang; T M Huang; S C Tsai; C M Teng; C C Wu; F C Cheng; S C Kuo
Journal:  J Med Chem       Date:  2001-10-25       Impact factor: 7.446

5.  Synthesis and antitumor activity of some substituted indazole derivatives.

Authors:  Najat Abbassi; El Mostapha Rakib; Hakima Chicha; Latifa Bouissane; Abdellah Hannioui; Cinzia Aiello; Rosaria Gangemi; Patrizio Castagnola; Camillo Rosano; Maurizio Viale
Journal:  Arch Pharm (Weinheim)       Date:  2014-02-19       Impact factor: 3.751

6.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.